Zobrazeno 1 - 10
of 10
pro vyhledávání: '"G Vezyroglou"'
Autor:
P Konstantopoulou, G Vezyroglou, E Griva, D Rontogianni, S Papazoglou, Panagiotis Athanassiou, T Kontomerkos, I Kostoglou-Athanassiou
Publikováno v:
Speaker abstracts 2001.
Background Rheumatoid arthritis (RA) is accompanied by haematological abnormalities. It is well known that anaemia in RA may have plural aetiology, however no correlation has been performed between anaemia and the morphology of blood cell precursors
Autor:
P Dimou, G Vezyroglou, A Theodorou, A Elezoglou, P Konstantopoulou, I Kostoglou-Athanassiou, Panagiotis Athanassiou, A Kotrotsios
Publikováno v:
Speaker abstracts 2001.
Background Rheumatoid arthritis (RA) is characterised by aberrations of the immune system. Moreover, treatment of RA patients involves agents, which induce immunosuppression. However, it has not yet been clarified whether RA or its primary treatment
Autor:
G Papadimitriou, K Michelidakis, C Antoniadis, J Myriokefalitakis, A Kotrotsios, G Vezyroglou
Publikováno v:
Speaker abstracts 2001.
Background Psychiatric symptoms occur in patients with chronic pain. It is well known that patients with rheumatoid arthritis present symptoms of depression to various degrees of intensity. Primary fibromyalgia syndrome is a form of non articular rhe
Autor:
C Koutsia-Karouzou, E Orkopoulou, K Themeli-Digalaki, Panagiotis Athanassiou, R Karidis, A Elezoglou, A Theodorou, G Vezyroglou
Publikováno v:
Speaker abstracts 2001.
Background Parvovirus B19 may cause an acute or chronic polyarthropathy, which in many cases fulfils the criteria of the American College of Rheumatology for the diagnosis of rheumatoid arthritis (RA). Additionally, parvovirus B19 has been implicated
Autor:
A Boubougianni, A Elezoglou, A Akkizidou, G Vezyroglou, Panagiotis Athanassiou, G Papadimitriou, I Kostoglou-Athanassiou, C. Antoniades
Publikováno v:
Speaker abstracts 2001.
Background Methotrexate has been recognised as one of the main therapeutic agents used in rheumatoid arthritis (RA). However some of the adverse effects of low-dose methotrexate therapy and in particular pancytopenia have caused major concern. Object
Autor:
A Elezoglou, I Kostoglou-Athanassiou, Panagiotis Athanassiou, T Kontomerkos, E Griva, S Papazoglou, D Rontogianni, G Vezyroglou
Publikováno v:
Speaker abstracts 2001.
Background Systemic lupus erythematosus (SLE) is accompanied by haematological abnormalities. A very common haematological abnormality observed in SLE is anaemia. It is well known that anaemia in SLE may have many causes, however no correlation has b
Publikováno v:
The Journal of rheumatology. 23(4)
I addition to diabetes mellitus (DM), high incidence of common metabolic conditions such as dyslipidemia (DL) and hyperuricemia (HU) has been found in patients with diffuse idiopathic skeletal hyperostosis (DISH). Our objective was to confirm such ob
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.